UGT1A1 and cancer: Five core ADME genes coding for phase II drug metabolism enzymes showed significant associations of their intratumoral expression levels with OS rates in cancers, including GSTP1, NAT1, UGT1A1, UGT2B15, UGT2B7 (Figure 3, Table 2).